A randomized unblinded trial to compare effects of intensive versus conventional lipid-lowering therapy in patients undergoing renal artery stenting.

CONCLUSIONS: In patients with severe ARAS undergoing stent placement, intensive lipid lowering showed significant benefits in renal protection over conventional lipid-lowering therapy. PMID: 31235418 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31235418?dopt=Abstract

Source: Journal of Cardiology - June 20, 2019 Category: Cardiology Authors: Peng M, Dong H, Jiang X, Che W, Zou Y, Zhang Y, Liu L Tags: J Cardiol Source Type: research